Knight Therapeutics Inc. (TSX:GUD)
6.44
-0.05 (-0.77%)
Aug 12, 2025, 10:47 AM EDT
Intra-Cellular Therapies Market Cap
Knight Therapeutics has a market cap or net worth of CAD 646.75 million as of August 12, 2025. Its market cap has increased by 12.37% in one year.
Market Cap
646.75M
Enterprise Value
635.07M
Revenue
384.56M
Ranking
n/a
PE Ratio
1,688.64
Stock Price
$6.44
Market Cap Chart
Since March 3, 2014, Knight Therapeutics's market cap has increased from 84.40M to 646.75M, an increase of 666.31%. That is a compound annual growth rate of 19.47%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 11, 2025 | 646.75M | 20.76% |
Dec 31, 2024 | 535.57M | -0.95% |
Dec 29, 2023 | 540.73M | -7.35% |
Dec 30, 2022 | 583.64M | -7.29% |
Dec 31, 2021 | 629.56M | -9.50% |
Dec 31, 2020 | 695.69M | -32.33% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Green Thumb Industries | 2.28B |
Curaleaf Holdings | 2.14B |
Sienna Senior Living | 1.72B |
dentalcorp Holdings | 1.62B |
Trulieve Cannabis | 1.51B |
WELL Health Technologies | 1.24B |
Cronos Group | 1.22B |
Extendicare | 1.10B |